Trials / Completed
CompletedNCT02094950
Acupuncture Feasibility Trial for Dyspnea in Lung Cancer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm clinical trial to establish the feasibility of conducting a clinical trial of acupuncture in reducing dyspnea among lung cancer survivors who have completed chemoradiotherapy. Twelve subjects with dyspnea will be recruited to this clinical trial. Up to 10 sessions of acupuncture will be delivered over the course of 8-10 weeks. The primary outcome will be dyspnea as measured by the English version of the Cancer Dyspnea Scale at the completion of the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Acupuncture |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2015-07-15
- Completion
- 2015-07-15
- First posted
- 2014-03-24
- Last updated
- 2019-07-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02094950. Inclusion in this directory is not an endorsement.